Form 4 for DNA Ginkgo Bioworks Holdings, Inc.

Accepted 2023-12-12 00:00:00 ET · period of report 2023-12-08 · accession 0001127602-23-029447 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DI	2023-12-12	2023-12-12	DNA	Shetty Reshma P.	See remarks, Dir, 10%	G - Gift	$0.00	-200.0K	12.45M	-2%	$0
DI	2023-12-12	2023-12-08	DNA	Shetty Reshma P.	See remarks, Dir, 10%	C - Cnv Deriv	—	+200.0K	12.65M	+2%	—
DI	2023-12-12	2023-12-08	DNA	Shetty Reshma P.	See remarks, Dir, 10%	C - Cnv Deriv	—	-200.0K	69.99M	-0.3%	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2023-12-12	G	D	200,000	$0.00	12,449,844	I By Spouse	—	—
2	Common	Class A Common Stock	2023-12-08	C	A	200,000	—	12,649,844	I By Spouse	—	—	(F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
3	Derivative	Class B Common Stock	2023-12-08	C	D	200,000	—	69,989,783	I By Bartholomew Canton Living Trust	— · — to —	200,000 Class A Common Stock	(F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.